20 articoli
A comprehensive review reveals methylene blue's expanding role from toxicology emergencies to perioperative care, neurology, and oncology.
Current labeling urges nursing mothers to pause breastfeeding for 8 days after methylene blue, but the underlying evidence is thin.
FDA-approved methylene blue reduced delirium-like behavior in surgical mice by suppressing neuroinflammation and repairing the blood-brain barrier.
A meta-analysis of 15 studies finds methylene blue therapy significantly reduces mortality in ICU septic shock patients, with hemodynamic benefits.
A 2025 review examines how methylene blue's nitric oxide inhibition can restore vascular tone in septic and vasoplegic shock patients.
A primate study shows methylene blue treats fatal cerebral malaria and uncovers neutrophil-linked genes as diagnostic biomarkers.
Uno studio RCT multicentrico su 566 pazienti avviato in tutta la Cina per determinare se il blu di metilene somministrato precocemente riduce la mortalità a 28 giorni nello shock settico dipendente da vasopressori ad alto dosaggio.
Uno studio su 200 pazienti rileva che l'uso precoce di methylene blue nello shock vasoplegico post-bypass dimezza i ricoveri in terapia intensiva e riduce i tassi di insufficienza renale.
Un caso clinico riportato dal Surrey and Sussex NHS Trust evidenzia i rischi di stravaso di blu di metilene nella mano e nell'avambraccio durante la chirurgia paratiroidea.
A comprehensive review reveals how advanced oxidation processes can efficiently degrade methylene blue, a persistent textile pollutant threatening human health.
Adding methylene blue to ropivacaine in a serratus anterior plane block significantly prolongs pain relief up to 72 hours post-op.
A comprehensive review reveals how plant-derived nanomaterials catalytically neutralize toxic dyes and nitrophenols from industrial wastewater with remarkable efficiency.
New research shows blue light triggers harmful changes in retinal cells by disrupting mitochondrial function, offering targets for AMD prevention.
MethylCog, a 29-CpG blood test, indexes general cognitive ability and improves mild cognitive impairment detection beyond age and sex alone.
A 4-week-old infant developed severe methemoglobinemia after EMLA cream was applied for circumcision, highlighting hidden dangers of topical anesthetics.
Una meta-analisi Cochrane di 17 RCT rileva che la TURBT a luce blu riduce la recidiva e la progressione del cancro alla vescica, in particolare nei pazienti a rischio intermedio e alto.
Morning blue light exposure stabilized attention during cognitive tasks, reducing moment-to-moment mental variability in young adults.
A 303-tumor study shows DNA methylation arrays can classify neuroblastoma into prognostically meaningful subgroups, potentially replacing multiple genomic tests.
La cianidina-3-O-glucoside, un'antocianina naturale, riduce i linfociti T regolatori (Treg) immunosoppressori e rallenta la crescita del mieloma multiplo in studi su topi e cellule.
Delphinidin, a natural anthocyanin, prevented microglial senescence via AMPK/SIRT1 signaling, reducing amyloid plaques and restoring cognition in AD mice.
